Sun Ai-Li
Department of Chemistry and Chemical Engineering, Xinxiang University, Xinxiang 453000, P.R. China.
Analyst. 2015 Dec 7;140(23):7948-54. doi: 10.1039/c5an01827g. Epub 2015 Oct 26.
A new electrochemical immunosensor with signal enhancement was designed for sensitive detection of disease-related protein (human carbohydrate antigen 19-9, CA 19-9 used in this case). The assay was carried out on a capture antibody-modified screen-printed carbon electrode with a sandwich-type mode by using detection antibody-functionalized nanogold-encapsulated poly(amidoamine) dendrimer (AuNP-PAAD). The AuNP-PAAD was first synthesized through the in situ reduction method and functionalized with the polyclonal rabbit anti-human CA 19-9 antibody. Upon target CA 19-9 introduction, a sandwiched immunocomplex could be formed between the capture antibody and detection antibody. Accompanying the AuNP-PAAD, the electrocatalytic activity of the carried gold nanoparticles toward the hydrogen evolution reaction (HER) allowed the rapid quantification of the target analyte on the electrode. The amplified electrochemical signal mainly derived from AuNP-catalyzed HER in an acidic medium. Under optimal conditions, the immuno-HER assay displayed a wide dynamic concentration range from 0.01 to 300 U mL(-1) toward target CA 19-9 with a detection limit (LOD) of 6.3 mU mL(-1). The reproducibility, precision, specificity and stability of our strategy were acceptable. Additionally, the system was further validated by assaying 13 human serum specimens, giving well matched results obtained from the commercialized enzyme-linked immunosorbent assay (ELISA) method.
设计了一种具有信号增强功能的新型电化学免疫传感器,用于灵敏检测疾病相关蛋白(本案例中使用的人糖类抗原19-9,CA 19-9)。该检测在捕获抗体修饰的丝网印刷碳电极上以夹心模式进行,通过使用检测抗体功能化的纳米金包封聚(酰胺胺)树枝状大分子(AuNP-PAAD)。AuNP-PAAD首先通过原位还原法合成,并用兔抗人CA 19-9多克隆抗体进行功能化。引入目标CA 19-9后,捕获抗体和检测抗体之间可形成夹心免疫复合物。伴随着AuNP-PAAD,所携带的金纳米颗粒对析氢反应(HER)的电催化活性使得能够在电极上快速定量目标分析物。放大的电化学信号主要源于酸性介质中AuNP催化的HER。在最佳条件下,免疫HER检测对目标CA 19-9的动态浓度范围为0.01至300 U mL(-1),检测限(LOD)为6.3 mU mL(-1)。我们策略的重现性、精密度、特异性和稳定性均令人满意。此外,通过检测13份人血清标本对该系统进行了进一步验证,得到的结果与商业化酶联免疫吸附测定(ELISA)方法获得的结果非常匹配。